Zobrazeno 1 - 10
of 47
pro vyhledávání: '"J S Fischer"'
Autor:
Lawrence Jacobs, K. E. Wende, Muriel D. Lezak, Anna L. Davidson, J. S. Fischer, Dennis Bourdette, Jack H. Simon, Mark Schacter, John R. Richert, Robert M. Herndon, Jordan Grafman, David W. Shucard, Katherine Kawczak Perkins, Carl V. Granger, Donald E. Goodkin, Kathleen M. Hovey, Diane Cookfair, Roger L. Priore, Richard A. Rudick, Mariska Kooijmans-Coutinho, Danielle Barilla-Clark, Andres M. Salazar
Publikováno v:
Annals of Neurology. 48:885-892
Cognitive dysfunction is common in multiple sclerosis (MS), yet few studies have examined effects of treatment on neuropsychological (NP) performance. To evaluate the effects of interferon β-1a (IFNβ-1a, 30 μg administered intramuscularly once wee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::207efa4594055dd7c59ff5f950232e82
https://doi.org/10.1002/1531-8249(200012)48:6<885::aid-ana9>3.0.co
https://doi.org/10.1002/1531-8249(200012)48:6<885::aid-ana9>3.0.co
Autor:
J. S. Fischer, Amy J. Jak, L. A. Mertz, Jeffrey A. Cohen, D. M. Bolibrush, Thomai Skaramagas, Judith E. Kniker, Gary Cutter
Publikováno v:
Neurology. 54:802-806
Objective: To assess practice effects, and intrarater and interrater reliability of the MS functional composite (MSFC) outcome measure. Background: To address the poor reliability and insensitivity to change of available MS clinical rating scales, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd6942c25d140bd09b48f7295d1c62e2
https://doi.org/10.1212/wnl.54.4.802
https://doi.org/10.1212/wnl.54.4.802
Publikováno v:
Multiple Sclerosis Journal. 5:244-250
Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales such as the EDSS are inadequate in their assessment of key clinical dimensions of MS (e.g.,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c3174a7e08ec20f9477e9050c7f0e54
https://doi.org/10.1177/135245859900500409
https://doi.org/10.1177/135245859900500409
Autor:
J. S. Fischer, Paul Ritvo, Howard Andrews, Nicholas G. LaRocca, Deborah M. Miller, Donald W. Paty
Publikováno v:
Multiple Sclerosis Journal. 5:251-259
Multiple sclerosis (MS) and its treatment have broad-ranging effects on quality of life. This article reviews recent efforts to assess the impact of MS on activities of daily living (ADLs) and health-related quality of life (HRQL), and describes the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0576c919e6f6ebe0cb84f7699b13a8e
https://doi.org/10.1177/135245859900500410
https://doi.org/10.1177/135245859900500410
Autor:
N. A. Simonian, Kathy O'Reilly, J. S. Fischer, Michele K. Mass, Jonathan Braiman, Lawrence Jacobs, K. E. Wende, Frederick E. Munchsauer, Barbara J. Scherokman, Carol M. Brownscheidle, Carl V. Granger, Robert M. Herndon, David S. Dougherty, David M. Bartoszak, Donald E. Goodkin, John R. Richert, Bianca Weinstock-Guttman, Richard A. Rudick, Roger L. Priore, Andres M. Salazar, Diane Cookfair, Stanley L. Cohan, Ruth H. Whitham, Dennis Bourdette, Michael E. Coats, R. P. Kinkel, Richard M. Ransohoff, Patrick M. Pullicino, Jack H. Simon
Publikováno v:
Journal of Neuroimmunology. 93:8-14
Background and objective : This report provides results of CSF analyses done in a subset of relapsing remitting MS patients participating in a placebo-controlled, double-blind, phase III clinical trial of IFNβ-Studies supported by the National Multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::694ae9218bef5793925f24d4e27180ff
https://doi.org/10.1016/s0165-5728(98)00174-x
https://doi.org/10.1016/s0165-5728(98)00174-x
Autor:
J. S. Fischer, John S. Wiebe, Janet L. Taylor, James E. Aikens, Neil H. Pliskin, Lance M. McCracken, Mark A. Reinecke
Publikováno v:
Journal of Behavioral Medicine. 22:127-142
Overlap between depression scale item content and medical symptoms may exaggerate depression estimates for patients with multiple sclerosis (MS). We reconsider Mohr and co-workers' (1997) recommendation to omit Beck Depression Inventory (BDI) items a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::968dd01d398f9060b036b414829d5080
https://doi.org/10.1023/a:1018731415172
https://doi.org/10.1023/a:1018731415172
Autor:
Frederick Munschauer, J. S. Fischer, Michele Mass, Diane Cookfair, John R. Richert, Ruth H. Whitham, Dennis Bourdette, Michael E. Coats, M. Campion, Barbara J. Scherokman, Carol M. Brownscheidle, Carl V. Granger, R. P. Kinkel, Donald E. Goodkin, Robert M. Herndon, Roger L. Priore, Lawrence Jacobs, Bianca Weinstock-Guttman, John J. Alam, RA Rudick, David S. Dougherty, Stanley Cohan, Andres M. Salazar, K. E. Wende, David M. Bartoszak, Patrick M. Pullicino, Jack H. Simon, J. Braiman
Publikováno v:
Multiple Sclerosis. 4:480-486
We compared the ability of the Kurtzke Expanded Disability Status Scale (EDSS) and a composite outcome of non-physician-based measures of time to ambulate 25 feet (TA) and manual dexterity (the Box and Block Test [BBT], and 9-Hole Peg Test [9HPT]) to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2920bfba3e37e14060f1964b94d64338
https://doi.org/10.1191/135245898678845179
https://doi.org/10.1191/135245898678845179
Autor:
Ann Scherzinger, Bianca Weinstock-Guttman, Frederick Munschauer, Carol M. Brownscheidle, Carl V. Granger, Roger L. Priore, Richard A. Rudick, John J. Alam, Patrick M. Pullicino, Lawrence Jacobs, Jack H. Simon, Robert M. Herndon, Michele Mass, Andres M. Salazar, Jeanelle Sheeder, K. E. Wende, N. A. Simonian, Stanley Cohan, Michelle Lajaunie, David S. Dougherty, Jonathan Braiman, Diane Cookfair, J. S. Fischer, Ruth H. Whitham, Michael E. Coats, Mary Joel Meyer, Donald E. Goodkin, David M. Bartoszak, Kim Choi, Dennis Bourdette, Barbara J. Scherokman, John R. Richert, R. P. Kinkel, Anna L. Martens-Davidson, M. Campion
Publikováno v:
Annals of Neurology. 43:79-87
The Multiple Sclerosis Collaborative Research Group trial was a double-blind, randomized, multicenter, phase III, placebo-controlled study of interferon beta-1a (IFNbeta-1a; AVONEX) in relapsing forms of multiple sclerosis. Initial magnetic resonance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0e5eab1a6185ca6b61e8aaa1f979845
https://doi.org/10.1002/ana.410430114
https://doi.org/10.1002/ana.410430114
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
Autor:
Brian G. Weinshenker, John Petkau, Aaron E. Miller, J. S. Fischer, Gary Cutter, Richard A. Rudick, Fred D. Lublin, Ernest Willoughby, Alan J. Thompson, George W. Ellison, Christian Confavreux, Joy Wallenberg, Stephen M. Rao, Karl Syndulko, Jack P. Antel, Stephen C. Reingold
Publikováno v:
ResearcherID
This article provides recommendations from the National Multiple Sclerosis Society's Clinical Outcomes Assessment Task Force. The Task Force was appointed in 1994 and charged with recommendending improved approaches for clinical outcomes assessment i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14ca2bc12f5e154f28ab93d149ab7211
https://doi.org/10.1002/ana.410420318
https://doi.org/10.1002/ana.410420318
Autor:
R. H. Whitham, D. S. Dougherty, P. M. Pullicino, David M. Bartoszak, Michael E. Coats, J. S. Fischer, Jack H. Simon, C. M. Brownscheidle, L. D. Jacobs, Richard A. Rudick, B. Weistock-Guttman, N. A. Simonian, B. J. Scherokman, J. R. Richert, C. V. Granger, Robert M. Herndon, Michele Mass, D. L. Cookfair, Andres M. Salazar, R. L. Priore, J. J. Alam, R. P. Kinkel, Dennis Bourdette, F. E. Munschauer, Jonathan Braiman, S. L. Cohan, Donald E. Goodkin, M. K. Campion
Publikováno v:
Neurology. 49:358-363
Background and Objective: A phase III double-blind, placebo-controlled clinical trial demonstrated that interferon beta-la (IFNβ-1a) (Avonex, Biogen) significantly delayed progression of disability in relapsing MS patients. The primary clinical outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e29bb515d0eef4fe10f80d9ae4105c35
https://doi.org/10.1212/wnl.49.2.358
https://doi.org/10.1212/wnl.49.2.358